Seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-25 season, according to ...

RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...

Moderna Inc (NASDAQ:MRNA) saw its stock rise 3.8% after announcing that its experimental flu vaccine, mRNA-1010, delivered ...

Moderna today reported promising relative vaccine efficacy (rVE) findings from a phase 3 trial of its seasonal mRNA flu ...

H1N1 is a pandemic, meaning it is a global epidemic. It's the first flu pandemic in 41 years. The federal response looks like a war room, but the officers are in the U.S. public health service, ...

At 21-42 days post-vaccination, the geometric mean haemagglutination inhibition titres were 32% higher for H1N1, 55% for H3N2, and 39% for B strains among recipients of the high-dose vaccine than ...

A recombinant flu vaccine (Flublok) contains no eggs and was recently approved for use in individuals aged 9 years or older ...

While H1N1 disproportionately affected people under age 65, those at greatest risk from covid-19, the illness caused by the coronavirus, ...

The most likely explanation is that older adults were exposed to a similar strain - another type of H1N1 - that was the primary flu in circulation from about 1918 to 1957. After 1957, a different ...

The new H1N1 virus was first identified in April 2009 after a rash of outbreaks in Mexico and the U.S. that quickly spread around the globe. Health officials are worried about this strain because ...

The H1N1 (swine) flu virus won't resemble the deadly 1918 flu pandemic, but it still "poses a serious health threat" to Americans, the President's Council of Advisors on Science and Technology ...

Profits from the H1N1 flu virus are nothing to sneeze at. Oct. 14, 2009— -- Americans are still debating whether to roll up their sleeves for a swine flu shot, but companies have already ...